Recent progress on the pro and cons of biological effects of nanomaterials

Progress in Biochemistry and Biophysics

Volumn 35, Issue 9, 2008, Pages 998-1006

  Zhou, Guo Qiang ^a,c   Chen, Chun Ying ^a,b   Li, Yu Feng ^a   Li, Wei ^a,c   Gao, Yu Xi ^a   Zhao, Yu Liang ^a,b  

^a INSTITUTE OF HIGH ENERGY PHYSICS   (China)

^b NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Biomedical application; Environmental health; Nanomaterials; Nanotoxicology

Indexed keywords

EID: 57349117257     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ofultrafine particles. Environ Health Perspect, 2005, 113: 823-839
2. Wu X, Liu H, Liu J, et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol, 2003, 21(1): 41-46
3. Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials, 2002, 23(7): 1553-1561
4. Gao X, Cui Y, Levenson R M, et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol, 2004, 22(8): 969-976
5. Qu L, Cao W B, Zhao Y L, et al. Study of rare earth encapsulated carbon nanomaterials for biomedical uses. J Alloy Compound, 2006, 408: 400-404
6. Moghimi S M, Hunter A C, Murray J C. Nanomedicine: current status and future prospects. FASEB J, 2005, 19(3): 311-330
7. Allen T N, Cullis P R. Drug delivery systems: entering the mainstream. Science, 2004, 303(5665): 1818-1821
8. Tang N, Du G, Wang N, et al. Improving penetration in tumors with nano-assemblies of phospholipids and doxorubicin. J Natl Caner I, 2007, 99(13): 1004-1015
9. 2 interacting with living cells using fluorescence microscopy. Chinese Sci Bull, 2006,51(9):1060-1064
10. O'Neal D P, Hirsch L R, Halas N J, et al. Photothermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett, 2004, 209(2):171-176
11. 111In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin Cancer Res, 2005, 11(19pt 2): 7087s-7092s
12. El-Sayed I H, Huang X, El-Sayed M A. Selective laser photothermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett, 2006, 239(1): 129-135
13. n nanoparticles: antineoplastic activity of high efficiency and low toxicity. Nano Lett, 2005, 5(10): 2050-2057
14. n nanoparticles in tumor-bearing mice. Biomed Pharm, 2006, 71(6): 872-881
15. Gopalan B, Ito I, Branch C D, et al. Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response. Technol Cancer Res Treat, 2004, 3(6): 647-657
16. Li Z, Zhu S, Gan K, et al. Poly-L-lysine-modified silica nanoparticles: a potential oral gene delivery system. J Nanosci Nanotechnol, 2005, 5(8): 1199-1203
17. Dufes C, Keith W N, Bilsland A, et al. Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. Cancer Res, 2005, 65(18): 8079-8084
18. Kaul G, Amiji M. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm Res, 2005, 22(6): 951-961
19. Prabha S, Labhasetwar V. Nanoparticle-mediated wildtype p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Mol Pharm, 2004, 1(3): 211-219
20. Peters A, Liu E, Verrier R L, et al. Air pollution and incidence of cardiac arrhythmia. Epidemiology, 2000, 11(1): 11-17
21. Pope C A , Burnett R T, Thurston G D, et al. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation, 2004, 109(1): 71-77
22. Dockery D W, Luttmann-Gibson H, Rich D Q, et al. Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implanted cardioverter defibrillators. Environ Health Perspect, 2005, 113(6): 670-674
23. Batalha J R, Saldiva P H, Clarke R W, et al. Concentrated ambient air particles induce vasoconstriction of small pulmonary arteries in rats. Environ Health Perspect, 2002, 110(12): 1191-1197
24. Wellenius G A, Coull B A, Godleski J J, et al. Inhalation of concentrated ambient air particles exacerbates myocardial ischemia in conscious dogs. Environ Health Perspect, 2003, 111(4): 402-408
25. Seaton A, MacNee W, Donaldson K, et al. Particulate air pollution and acute health effects. Lancet, 1995, 345(8943): 176-178
26. Nurkiewicz T R, Porter D W, Barger M, et al. Particulate matter exposure impairs systemic microvascular endothehum-dependent dilation. Environ Health Perspect, 2004, 112(13): 1299-1306
27. Li Z, Carter J D, Dailey L A, et al. Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type I receptor. Environ Health Perspect, 2005a, 113(8): 1009-1014
28. Geiser M, Rothen R B, Kapp N, et al. Ultrafine particles cross cellularmembranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect, 2005, 113(11): 1555-1560
29. Brown D M, Wilson M R, MacNee W, et al. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol, 2001, 175(3): 191-199
30. Dick C A, Brown D M, Donaldson K, et al. The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types. Inhal Toxicol, 2003, 15(1): 39-52
31. Oberdörster G. Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health, 2001, 74(1): 1-8
32. Donaldson K, Tran C L. Inflammation caused by particles and fibers. Inhal Toxicol, 2002, 14(1): 5-27
33. Nel A, Xia T, Madler L, et al. Toxic potential of materials at the nanolevel. Science, 2006, 311(5761): 622-627
34. Oberdörster G, Ferin J, Lehnert B E. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect, 1994, 102(suppl 5): 173-179
35. Edilberto B, James B M, Brian A W, et al. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci, 2004, 77(2): 347-357
36. Lam C W, James J T, McCluskey R, et al. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci, 2004, 77(1): 126-134
37. Shvedova A A, Kisin E R, Mercer R, et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol, 2005, 289(5): L698-L708
38. Warheit D B, Laurence B R, Reed K L, et al. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci, 2004, 77(1): 117-125
39. Hoet P H, Bruske-Hohlfeld I, Salata O V. Nanoparticles-known and unknown health risks. J Nanobiotechnology, 2004, 2(1): 12
40. Wang J X, Zhou G Q, Chen C Y, et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett, 2007, 168(2): 176-185
41. Bodian D, Howe H A. Experimental studies on intraneural spread of poliomyelitis virus. Bull Johns Hopkins Hos, 1941a, 69: 248-267
42. Howe H A, Bodian D. Portals of entry of poliomyelitis virus in the chimpanzee. Proc Soc Exp Biol Med, 1940, 43: 718-721
43. Adams R J, Bray D. Rapid transport of foreign particles microinjected into crab axons. Nature, 1983, 303(6): 718-720
44. de Lorenzo A J. The olfactory neuron and the blood-brain barrier. In: Taste and Smell in Vertebrates (Wolstenholme G, Knight J, eds). London: Churchill, 1970. 151-176
45. Oberdörster G, Sharp Z, Atudorei V, et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health, 2002, A65(20): 1531-1543
46. Oberdörster G, Sharp Z, Atudorei V, et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol, 2004, 16(6/7): 437-445
47. Feikert T, Mercer P, Corson N, et al. Inhaled solid ultrafine particles (UFP) are efficiently translocated via neuronal naso-olfactory pathways. Toxicologist, 2004, 78(suppl 1): 435-436
48. Fechter L D, Johnson D L, Lynch R A. The relationship of particle size to olfactory nerve uptake of a non-soluble form of manganese into brain. Neurotoxicology, 2002, 23(2): 177-183
49. Wang J X, Chen C Y, Sun J, et al. HEP&NP, 2005, 29(suppl): 76-79
50. 2 particles in the olfactory bulb of mice after nasal inhalation using microbeam SRXRF mapping techniques. J Radioanal Nucl Chem, 2007b, 272(3): 527-531
51. Wang J X, Li Y F, Zhou G Q, et al. Chin J Prev Med, 2007, 41(2): 91
52. Tinkle S S, Antonini J M, Rich B A, et al. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect, 2003, 111(9): 1202-1208
53. Lademann J, Weigmann H, Rickmeyer C, et al. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol, 1999, 12(5): 247-256
54. Kim S, Lim Y S, Soltesz E G, et al. Near infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol, 2004, 22(1): 93-97
55. Chen B, Wilson S, Das M, et al. Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics. Proc Natl Acad Sci USA, 1998, 95: 10809-10813
56. Dreher K L. Toxicological highlight: health and environmental impact of nanotechnology. Toxicol Sci, 2004, 77: 3-5